<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actbiotech</journal-id><journal-title-group><journal-title xml:lang="ru">Актуальная биотехнология</journal-title><trans-title-group xml:lang="en"><trans-title>Topical biotechnology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2304-4691</issn><publisher><publisher-name>ВГУИТ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20914/2304-4691-2019-3-603-604</article-id><article-id custom-type="elpub" pub-id-type="custom">actbiotech-4376</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>НОВЫЙ СПОСОБ ВЫСОКОЭФФЕКТИВНОЙ ВНУТРИКЛЕТОЧНОЙ ДОСТАВКИ БИОМОЛЕКУЛ НА ОСНОВЕ МОНОСЛОЕВ ЗОЛОТЫХ НАНОЧАСТИЦ С ПРИМЕНЕНИЕМ ИК-ЛАЗЕРА</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авдеева</surname><given-names>Е. С.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пылаев</surname><given-names>Т. Е.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хлебцов</surname><given-names>Н. Г.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Институт биохимии и физиологии растений и микроорганизмов РАН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>18</day><month>09</month><year>2019</year></pub-date><volume>0</volume><issue>3</issue><fpage>603</fpage><lpage>604</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Авдеева Е.С., Пылаев Т.Е., Хлебцов Н.Г., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Авдеева Е.С., Пылаев Т.Е., Хлебцов Н.Г.</copyright-holder><copyright-holder xml:lang="en">Авдеева Е.С., Пылаев Т.Е., Хлебцов Н.Г.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actbio-vsuet.ru/jour/article/view/4376">https://www.actbio-vsuet.ru/jour/article/view/4376</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Glover D.J., Lipps H.J., Jans D.A. Towards safe, non-viral therapeutic gene expression in humans // Nat Rev Genet. 2005. V. 6 (4). P. 299-310.</mixed-citation><mixed-citation xml:lang="en">Glover D.J., Lipps H.J., Jans D.A. Towards safe, non-viral therapeutic gene expression in humans // Nat Rev Genet. 2005. V. 6 (4). P. 299-310.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pack D.W., Hoffman A.S., Pun S., Stayton P.S. Design and development of polymers for gene delivery // Nat Rev Drug Discov 2005. V. 4 (7). P. 581-93.</mixed-citation><mixed-citation xml:lang="en">Pack D.W., Hoffman A.S., Pun S., Stayton P.S. Design and development of polymers for gene delivery // Nat Rev Drug Discov 2005. V. 4 (7). P. 581-93.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart M.P., Langer R., Jensen K.F. Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts // Chem. Rev. 2018. V. 118 (16). P. 7409-7531.</mixed-citation><mixed-citation xml:lang="en">Stewart M.P., Langer R., Jensen K.F. Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts // Chem. Rev. 2018. V. 118 (16). P. 7409-7531.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen G., Roy I., Yang C., Prasad P.N. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy // Chem. Rev. 2016. V. 116. P. 2826-2885.</mixed-citation><mixed-citation xml:lang="en">Chen G., Roy I., Yang C., Prasad P.N. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy // Chem. Rev. 2016. V. 116. P. 2826-2885.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lakshmanan S., Gupta G.K., Avci P., Chandran R., Sadasivam M., Jorge A.E.S., Hamblin M.R. Physical energy for drug delivery; poration, concentration and activation // Adv. Drug Deliv. Rev. 2014. V. 71. P. 98-114.</mixed-citation><mixed-citation xml:lang="en">Lakshmanan S., Gupta G.K., Avci P., Chandran R., Sadasivam M., Jorge A.E.S., Hamblin M.R. Physical energy for drug delivery; poration, concentration and activation // Adv. Drug Deliv. Rev. 2014. V. 71. P. 98-114.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pylaev T., Vanzha E., Avdeeva E., Khlebtsov B., Khlebtsov N. A novel cell transfection platform based on laser optoporation mediated by Au nanostar layers // Journal of Biophotonics. 2019. V. 12. Art. No e201800166.</mixed-citation><mixed-citation xml:lang="en">Pylaev T., Vanzha E., Avdeeva E., Khlebtsov B., Khlebtsov N. A novel cell transfection platform based on laser optoporation mediated by Au nanostar layers // Journal of Biophotonics. 2019. V. 12. Art. No e201800166.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Vanzha E., Pylaev T., Prilepskii A., Golubev A., Khlebtsov B., Bogatyrev V., Khlebtsov N. Cell culture surfaces with immobilized gold nanostars: a new approach for laser-induced plasmonic cell optoporation // Proc. SPIE. 2017. No 10336.</mixed-citation><mixed-citation xml:lang="en">Vanzha E., Pylaev T., Prilepskii A., Golubev A., Khlebtsov B., Bogatyrev V., Khlebtsov N. Cell culture surfaces with immobilized gold nanostars: a new approach for laser-induced plasmonic cell optoporation // Proc. SPIE. 2017. No 10336.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Pylaev T., Avdeeva E., Khlebtsov B., Zakharevich A., Khlebtsov N. A novel centrifuge-based approach for tunable 2D layering of plasmonic nanoparticles // Proc. SPIE. 2018. No110671I.</mixed-citation><mixed-citation xml:lang="en">Pylaev T., Avdeeva E., Khlebtsov B., Zakharevich A., Khlebtsov N. A novel centrifuge-based approach for tunable 2D layering of plasmonic nanoparticles // Proc. SPIE. 2018. No110671I.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
